Viewing Study NCT07285369


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2025-12-25 @ 8:34 PM
Study NCT ID: NCT07285369
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-11-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)
Sponsor: Agyany Pharma LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module